Form 4 · PG
Procter & Gamble CEO- Health Care Paul Gama reports an award of 12,517 shares
Paul Gama, Procter & Gamble's CEO- Health Care, filed a Form 4 on Oct 5, 2026 at 2:29 PM ET reporting transactions on Oct 1, 2026.
The filing reports 12,517 shares in a grant or award (code A).
After these transactions, the filing lists about 53,349 shares held directly.
Effect on holdings
Taken together, the rows reported here raised Paul Gama's directly held shares by 30.7%, from about 40,832 to about 53,349.
Reporting person
- Paul Gama, CEO- Health Care (as filed: Gama Paul)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | A | Common Stock | 12,517 | Acquired | 53,349 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Oct 5, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
Procter & Gamble company file → · More Procter & Gamble filings
Disclosures
- Editor holdings in PG
- The editor holds no position in Procter & Gamble (PG). As of Oct 25, 2026.
- Last updated
- Oct 25, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold PG.